Related Experiment Video
Updated: Aug 10, 2026
09:20
In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 24, 2010
The human papillomavirus E7 protein as a transforming and transactivating factor
1Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, MD 20892.
Biochimica Et Biophysica Acta
|May 25, 1993
Summary
Human papillomavirus (HPV) early proteins E6 and E7 disrupt cell regulation for viral replication. Understanding these oncogenes is key for developing antiviral and antitumor therapies.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human papillomavirus (HPV) early proteins, specifically E6 and E7, are implicated in subverting host cell regulatory pathways.
- These viral proteins interact with cellular regulatory proteins, including tumor suppressor gene products, to facilitate viral replication.
- Dysregulation of cellular pathways by HPV oncogenes leads to cellular hyperproliferation and abnormal differentiation.
Purpose of the Study:
- To investigate the role of early HPV genes, particularly E6 and E7, in cellular transformation and carcinogenic progression.
- To elucidate the mechanisms by which HPV proteins interact with cellular regulatory proteins.
- To identify potential therapeutic targets for antiviral and antitumor interventions based on the function of early HPV genes.
Main Methods:
- The study focuses on the mechanistic understanding of protein-protein interactions between HPV E6/E7 oncoproteins and host cellular regulatory proteins.
- Analysis of how these interactions lead to the subversion of normal cellular pathways, including tumor suppressor functions.
- Investigating the consequences of these disruptions on cellular proliferation and differentiation.
Main Results:
- Expression of high-risk HPV E6 and E7 oncoproteins is a critical factor in cellular transformation.
- HPV oncogenes induce hyperproliferation and disrupt normal cellular differentiation pathways through interactions with key cellular regulators.
- Additional cellular alterations are likely required for the progression of cancer.
Conclusions:
- Early HPV genes, E6 and E7, play a crucial role in initiating and potentially maintaining carcinogenic progression.
- Understanding the molecular mechanisms of HPV oncogene action provides insights into cancer development.
- Further research into these viral-host interactions may unveil novel strategies for antiviral therapies and antitumor treatments.
Related Concept Videos
02:33Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...